Live tape
Mentions 7d10,030MSFT1,864 mentions▲ +0.06GOOGL1,604 mentions▲ +0.02NFLX1,374 mentions+0.02NVDA1,204 mentions▲ +0.09QQQ1,145 mentions▲ +0.06SNDK1,006 mentions▲ +0.06META957 mentions▲ +0.04ASTS876 mentions▲ +0.06
Equity · Healthcare

BIOA

BIOA · NasdaqGS
Price · Chart Chart by TradingView

Crowd sentiment on BIOA · 30d

Method · 0 mentions
Bullish 0%
Neutral 100%
Bearish 0%

Across 0 classified mentions in the last 30 days, crowd sentiment for BIOA sits roughly neutral, with 0% reading bullish against 0% bearish across the classified sample.

BIOA insider trades

SEC Form 4
Date Insider Type Shares Value
30 Jun 2026 Barton Shane Principal Accounting Officer OPTION EXERCISE 20,216 $132K
30 Jun 2026 Barton Shane Principal Accounting Officer SELL 20,216 $509K
29 Jun 2026 Barton Shane Principal Accounting Officer OPTION EXERCISE 39,718 $263K
29 Jun 2026 Barton Shane Principal Accounting Officer SELL 42,350 $1.07M
23 Apr 2026 GOLDSTEIN DOV A MD Chief Financial Officer OPTION EXERCISE 3,542 $16K
01 Apr 2026 RUBIN PAUL D Chief Medical Officer OPTION EXERCISE 8,820 $45K
01 Apr 2026 RUBIN PAUL D Chief Medical Officer SELL 8,820 $157K
02 Mar 2026 RUBIN PAUL D Chief Medical Officer OPTION EXERCISE 7,433 $35K

BIOA earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-0.52 $3M
31 Dec 2025 FY 2025 $-2.24 $9M
30 Sep 2025 Q3 2025 $-0.56 $2M
30 Jun 2025 Q2 2025 $-0.60 $2M

Reported figures & scheduled dates · SEC EDGAR filings